Newsroom

For media inquiries, please contact 340B Health Senior Vice President of Communications Jon Tilton at jon.tilton@340bhealth.org​​​​​​​ or 202-536-2285.

• 340B HEALTH STATEMENT ON 340B DRUG PURCHASE DATA FOR 2023

  October 21, 2024 in 340B Health News Releases

• 340B HEALTH APPLAUDS HRSA’S ACTION TO PROTECT 340B FROM J&J’S REBATE SCHEME

  September 27, 2024 in 340B Health News Releases

• SENATE COMPANION BILL WOULD END DRUG COMPANY RESTRICTIONS ON 340B

  September 11, 2024 in 340B Health News Releases

• 340B HEALTH URGES HRSA TO BLOCK J&J PLAN TO REPLACE 340B DISCOUNTS WITH REBATES

  August 23, 2024 in 340B Health News Releases

• 340B HEALTH BOARD ELECTS TWO NEW MEMBERS

  May 30, 2024 in 340B Health News Releases

• STATEMENT ON NEW FEDERAL LEGISLATION TO RESTRICT 340B HOSPITAL ELIGIBILITY

  May 28, 2024 in 340B Health News Releases

• STATEMENT ON D.C. CIRCUIT APPEALS COURT DECISION ON DRUG COMPANIES’ 340B RESTRICTIONS

  May 22, 2024 in 340B Health News Releases

• REPORT: 340B HOSPITALS PRESCRIBE MEDICARE PART D DRUGS TO GREATER SHARES OF HISTORICALLY UNDERSERVED PATIENTS

  May 16, 2024 in 340B Health News Releases

• 340B HEALTH STATEMENT ON HRSA’S FINAL 340B ADMINISTRATIVE DISPUTE RESOLUTION (ADR) RULE

  April 18, 2024 in 340B Health News Releases

• NEW FEDERAL LEGISLATION WOULD END DRUG COMPANY RESTRICTIONS ON 340B

  March 12, 2024 in 340B Health News Releases

• STATEMENT ON SENATE 340B BIPARTISAN WORKING GROUP DISCUSSION DRAFT

  February 02, 2024 in 340B Health News Releases

• FEDERAL COURT RULES HRSA IS UNLAWFULLY RESTRICTING PATIENTS WHO QUALIFY FOR 340B

  November 06, 2023 in 340B Health News Releases